Skip to main content
Erschienen in: Journal of Medical Case Reports 1/2017

Open Access 01.12.2017 | Case report

Oral manifestations, dental management, and a rare homozygous mutation of the PRDM12 gene in a boy with hereditary sensory and autonomic neuropathy type VIII: a case report and review of the literature

verfasst von: Karim Elhennawy, Seif Reda, Christian Finke, Luitgard Graul-Neumann, Paul-Georg Jost-Brinkmann, Theodosia Bartzela

Erschienen in: Journal of Medical Case Reports | Ausgabe 1/2017

Abstract

Background

Hereditary sensory and autonomic neuropathy type VIII is a rare autosomal recessive inherited disorder. Chen et al. recently identified the causative gene and characterized biallelic mutations in the PR domain-containing protein 12 gene, which plays a role in the development of pain-sensing nerve cells. Our patient’s family was included in Chen and colleagues’ study. We performed a literature review of the PubMed library (January 1985 to December 2016) on hereditary sensory and autonomic neuropathy type I to VIII genetic disorders and their orofacial manifestations. This case report is the first to describe the oral manifestations, and their treatment, of the recently discovered hereditary sensory and autonomic neuropathy type VIII in the medical and dental literature.

Case presentation

We report on the oral manifestations and dental management of an 8-month-old white boy with hereditary sensory and autonomic neuropathy-VIII over a period of 16 years. Our patient was homozygous for a mutation of PR domain-containing protein 12 gene and was characterized by insensitivity to pain and thermal stimuli, self-mutilation behavior, reduced sweat and tear production, absence of corneal reflexes, and multiple skin and bone infections. Oral manifestations included premature loss of teeth, associated with dental traumata and self-mutilation, severe soft tissue injuries, dental caries and submucosal abscesses, hypomineralization of primary teeth, and mandibular osteomyelitis.

Conclusions

The lack of scientific knowledge on hereditary sensory and autonomic neuropathy due to the rarity of the disease often results in a delay in diagnosis, which is of substantial importance for the prevention of many complications and symptoms. Interdisciplinary work of specialized medical and dental teams and development of a standardized treatment protocols are essential for the management of the disease. There are many knowledge gaps concerning the management of patients with hereditary sensory and autonomic neuropathy-VIII, therefore more research on an international basis is needed.
Abkürzungen
CIPA
Congenital insensitivity to pain and anhidrosis
HSAN-VIII
Hereditary sensory and autonomic neuropathy type VIII
NGF
Nerve growth factor
OMIM
Online Mendelian Inheritance in Man
NTRK1
Neurotrophic tyrosine kinase-1 receptor
PKAN
Pantothenate kinase-associated neurodegeneration
PRDM12
PR domain-containing protein 12 gene

Background

Hereditary sensory and autonomic neuropathy (HSAN) comprises a group of genetic disorders involving sensory and autonomic dysfunctions [1]. HSAN was classified into five main types [2]. Later, it was modified into subtypes [35] according to gene mutations, mode of inheritance, and clinical characteristics. HSAN types VI and VII were mentioned in the classification of Haga et al. [5]: Online Mendelian Inheritance in Man (OMIM) 614653 and 615548 respectively. HSAN type VIII (OMIM 616488) was recently characterized by Chen et al. [6] as a rare autosomal recessive disorder. Our patient’s family was included in their study. General characteristics, mode of inheritance, onset, and genes involved in each type of HSAN are presented in Table 1.
Table 1
Classification of recent types and subtypes of hereditary sensory (and autonomic) neuropathy
Types of HSAN
OMIM
Inheri.
Onset
Clinical characteristics
Somatosensory modalities
Sweating
Genes/ locus
HSAN-IA [2, 25, 28, 33, 34]
162400
AD
Mostly adolescence to adulthood
Hearing loss, loss of distal reflexes/distal muscle weakness, (no autonomic dysfunction)
Loss of pain and temperature sensation, lancinating pain
Normal
SPTLC1/9q22.31
HSAN-IB [2, 25, 28, 3335]
608088
AD
Adulthood
Chronic cough, gastropharyngeal reflux, hearing loss, alacrima, impotence
Sensory loss, lancinating pain
Normal to mild distal hypohidrosis
SPTLC1/3p24-p22
HSAN-IC [2, 25, 28, 33, 34, 36]
613640
AD
Mostly adulthood
Ulcerative mutilations, variable distal motor involvement, distal muscle weakness, osteomyelitis
Loss of pain, lancinating pain, loss of temperature sensation in parts of the body, sensory loss in the upper and lower limbs
Normal
SPTLC2/14q24.3
HSN-ID [2, 25, 28, 33, 34, 37]
613708
AD
Adulthood
Ulcerative mutilations, trophic skin and nail changes, distal amyotrophy in the lower limbs
Distal sensory loss of the lower limbs
Normal
ATL1/14q22.1
HSN-IE [2, 25, 28, 33, 34, 38]
614116
AD
Adulthood
Ulcerative mutilations, hearing loss, dementia
Loss of all somatosensory modalities, lancinating pain
Normal
DNMT1/19p13.2
HSN-IF [2, 25, 28, 33, 34, 39]
615632
AD
Adulthood
No autonomic involvement, diminished tendon reflexes, painless ulceration of the feet
Distal sensory loss of the lower limbs
Normal
ATL3/11q13.1
HSAN-IIA [2, 25, 28, 33, 34, 40]
201300
AR
Childhood
Self-mutilation behavior resulting in extensive orofacial injuries, weakness, acropathy
Loss of pain, temperature and touch sensation, no autonomic dysfunction
Normal
WNK1/12p13.33
HSAN-IIB [2, 25, 28, 33, 34, 41]
613114
AR
Childhood
Ulcerative mutilation of hands, feet, and orofacial structures, osteomyelitis, urge incontinence
Impaired nociception
Hyperhidrosis
FAM134B/5p15.1
HSN-IIC [2, 25, 28, 33, 34, 42]
614213
AR
Childhood to adolescence
Ulcerative mutilation and orofacial injuries, absent deep tendon reflexes, minor distal weakness, distal numbness of the hands and feet
Impaired position vibration senses
N/A
KIF1A/2937.3
HSAN-IID [2, 4, 25, 28, 33, 34, 43]
243000
AR
Congenital or adolescence
Autonomic nervous dysfunction, hearing loss, hyposmia, bone dysplasia, orofacial self-mutilation injuries
Loss of pain and temperature sensation, hypogeusia
Hypohidrosis
SCN9A/2q24.3
HSAN-III [2, 26, 29, 33, 34, 44, 58 63–66]
223900
AR
Congenital
Profound autonomic dysfunction, vasomotor instability, absence of deep tendon reflexes, alacrima, impaired blood pressure regulation, failure to thrive, orofacial self-mutilation, absent fungiform papillae on the tongue, increased salivation, low caries index
Loss of pain and temperature sensation
Hyperhidrosis
IKBKAP/9q31.3
HSAN-IV [2, 8, 9, 11, 13, 14, 26, 28, 29, 34, 35, 4451]
256800
AR
Congenital
Self-mutilation with orofacial injuries, deep tendon reflexes usually intact, recurrent fever, corneal lesions, mental retardation, recurrent infections, skin hyperkeratosis and fissuring, generalized tonic-clonic seizures
Loss of pain and temperature sensation
Hypohidrosis to anhidrosis
NTRK1/1q23.1
HSAN-V [2, 26, 29, 34, 35, 52]
608654
AR
Congenital
Similar to HSAN IV
Loss of pain and reduced thermal sensation, loss of deep pain perception
Normal to hypohidrosis
NGFB/1p13.2
HSAN-VI [33, 53]
614653
AR
Congenital
Lack of psychomotor development, autonomic abnormalities, absence of deep tendon reflexes, feeding and respiratory difficulties, neonatal hypotonia, alacrima, blotching
Loss of pain and temperature sensation
N/A
DST/6p12.1
HSAN-VII [33, 54, 55]
615548
AD
Congenital
Self-mutilation, painless fractures, delayed motor development, gastrointestinal dysfunction
Loss of pain sensation
Hyperhidrosis
SCN11A/3p22.2
HSAN-VIII [6, 30]
616488
AR
Onset in infancy
Self-mutilation behavior with orofacial injuries, painless fractures, skin and bone infections, corneal injuries, no mental retardation
Reduced pain and temperature sensation
Hypohidrosis
PRDM12/9q34.12
HSN with spastic paraplegia [33, 34]
256840
AR
Early childhood
Mutilation acropathy, septic paraplegia
Loss of all somatosensory modalities
Normal
CCT5/5p15.2
AD autosomal dominant, AR autosomal recessive, ATL1 atlastin GTPase 1, ATL3 atlastin GTPase 3, CCT5 chaperonin TCP1 subunit 5, DNMT1 DNA (cytosine-5-)-methyltransferase 1, DST dystonin, FAM134B family with sequence similarity 134 member B, HSAN hereditary sensory and autonomic neuropathy, HSN hereditary sensory neuropathy, IKBKAP inhibitor of kappa light polypeptide gene enhancer in B-cells kinase complex-associated protein, Inheri. mode of inheritance, KIF1A kinesin family member 1A, N/A not available, NGFB nerve growth factor (beta polypeptide), NTRK1 neurotrophic tyrosine kinase-1 receptor, OMIM Online Mendelian Inheritance in Man, PRDM12 PR domain-containing protein 12, SCN9A sodium channel, voltage gated type IX alpha subunit, SCN11A sodium channel, voltage gated, type XI alpha subunit, SPTLC1, serine palmitoyltransferase long chain base subunit 1, SPTLC2, serine palmitoyltransferase long chain base subunit 2, WNK1 WNK lysine deficient protein kinase 1
HSAN-VIII is characterized by five main features: insensitivity to pain and thermal stimuli, self-mutilation behavior, altered sweat and tear formation, absence of corneal reflexes, and presence of repeated infections of the skin and bone [6]. The syndrome was confirmed in 21 patients [6] and 10 different homozygous mutations in the PR domain-containing protein 12 gene (PRDM12) were identified [6]. Mutations in the PRDM12 gene in humans cause developmental defects in the sensory neurons, leading to loss of pain perception. Great loss of the small myelinated Aδ fibers occurred in patients with HSAN-VIII. Skin biopsies revealed that the peripheral terminals of unmyelinated C fibers were altered [6].
Patients carrying PRDM12 mutations lack the sensation of acute pain and temperature. Thus, these patients have numerous injuries, which may lead to recurrent infections of skin and bones, and bone deformities later in life. In addition, they lack corneal reflexes, which leads to progressive corneal scarring. However, other senses like light touch, vibration, and proprioception are normal. The only autonomic dysfunction observed was the reduction in sweating and tears formation. Intellectual abilities in patients with HSAN-VIII are normal [6].
Insensitivity to pain leads to severe oral mutilations, such as tooth luxation, severe dental attrition, premature tooth loss, bite wounds, and ulcerations [79]. The tongue, followed by the lips, and the oral mucosa, are the most common sites of self-inflicted injuries [10, 11]. The diagnosis of HSAN is challenging due to its rarity, similarity in clinical presentation to other auto-aggression or self-mutilation diseases, and lack of simple diagnostic tests [12]. It is mainly confirmed by the clinical presentation, genetic analysis, pharmacological tests, and neuropathological examinations [13]. Management of patients affected by HSAN-VIII is complicated due to the patients’ lack of awareness and perception of pain.
We aimed to present the manifestations and dental management of a patient with HSAN-VIII harboring the homozygous mutation c.516G>C (p. Glu172Asp) in the PRDM12 gene [6], who has been followed up in our clinic for 16 years. A review on PubMed library (January 1985 to December 2016) on patients with HSAN with oral manifestations was performed (Table 2).
Table 2
Literature review concerning oral manifestations associated with hereditary sensory (and autonomic) neuropathy
Year of pub.
Authors
Type
Gene
Country/ ethnic group
Ts
N
Age
G
General characteristics
Oral manifestations
2016
Eregowda et al. [56]
IV
NTRK1
India/ Indian
CR
1
11 y
F
Thermal insensitivity, anhidrosis, low intelligence, deformed interphalangeal joints of fingers, corneal scarring, skin infections, osteomyelitis
Oral self-mutilation, dental traumata
2015
Ravichandra et al. [13]
IV
NTRK1
India/
N/A
CR
1
7 y
F
Insensitivity to pain and temperature, anhidrosis, self-mutilation, preservation of other sensory modalities, recurrent fever
Orofacial self-mutilation, dental traumata
2015
Ashwin et al. [11]
IV
NTRK1
India/
N/A
CS
8
4–17 y
6 M
2 F
Insensitivity to pain, self-mutilation, recurrent fever, recurrent infection in the lower limbs
Oral self-mutilation
2015
Chen et al. [6]
VIII
PRDM12
Inter/
Inter
GA
21
3–40 y
13 M
8 F
Insensitivity to pain and temperature, hypohidrosis, self-mutilation behavior, skin and bone infections, painless fractures, corneal injuries, no mental retardation
Orofacial self-mutilation
2014
Özkaya et al. [57]
IV
NTRK1
Turkey/
N/A
CR
1
10 y
M
Recurrent fever, anhidrosis, ulcers on the skin, osteomyelitis, hyperkeratotic lesions on elbows and knees
Orofacial self-mutilation
2014
Guven et al. [44]
IV
NTRK1
Turkey/
Turkish descent
CS
2
1 y, 17 y
M
Insensitivity to pain and temperature, self-mutilation behavior, non-healing skin, ulcerations on the dorsum of the hands, anhidrosis, hypo- and hyper-pigmented skin
Orofacial self-mutilation
2013
Gao et al. [8]
IV
NTRK1
China/
N/A
CR
1
8 m
M
Recurrent fevers, anhidrosis,
dry warm skin, congenital corneitis
Oral self-mutilation, dental caries, malocclusion, cleft palate
2013
Fruchtman et al. [58]
IV
N/A
Israel/
N/A
CS
30
1 m–15 y
16 M
14 F
Infections, fever, orthopedic lesions
Orofacial self-mutilation
2010
Hutton and McKaig [45]
V
N/A
UK/
N/A
CR
1
6 y
F
N/A
Orofacial self-mutilation
2010
Zilberman et al. [46]
III
N/A
Israel/
N/A
HA
17
N/A
N/A
N/A
Thicker enamel formation
2009
Neves et al. [9]
IV
NTRK1
Brazil/
N/A
CR
1
2 y
F
Unexplained fever episodes, anhidrosis, self-mutilation behavior, mental retardation
Oral self-mutilation
2009
Paduano et al. [59]
IV
N/A
Italy/
Italian descent
CR
1
8.11 y
M
Self-mutilation, recurrent fever, osteomyelitis
Oral ulcers, limited mouth opening
2008
Romero et al. [60]
IV
N/A
Spain/
N/A
CR
1
22 m
F
Self-mutilation, recurrent fever
Orofacial self-mutilation
2008
Singla et al. [47]
V
N/A
India/
Indian descent
CR
1
10 y
M
Insensitivity to pain, normal response to thermal stimuli, bilateral corneal opacities, hypoplasia of the nipples
Presence of severe maxillary ridge resorption, congenitally missing permanent teeth
2006
Butler et al. [25]
IV
NTRK1
Ireland/
N/A
CR
1
9 m
M
Self-mutilation injuries on wrist and feet, insensitivity to pain, normal reaction to thermal stimuli
Orofacial self-mutilation
2006
Schalka et al. [27]
IV
N/A
Brazil/
Caucasian
CR
1
16 m
F
Lack of painful stimuli, episodes of unexplained fever, hypohidrosis
Orofacial self-mutilation
2006
Siqueira et al. [48]
V
N/A
Brazil/
N/A
CS
2
22 y, 16 y
1 M
1 F
Insensitivity to pain, self-mutilation behavior
Orofacial self-mutilation
2003
Bonkowsky et al. [12]
IV
NTRK1
USA/
Northern European
CR
1
4 m
M
Hyperkeratosis on palms, skin fissuring
Orofacial self-mutilation
2002
Mass et al. [52]
III
N/A
Israel/ Ashkenazi-Jewish descent
CS
28
N/A
N/A
N/A
Low levels of mutans streptococci and lactobacilli in saliva, high salivary flow
2002
Wolf et al. [61]
III
N/A
Israel/ Ashkenazi-Jewish descent
CS
46
6–16 y
31 M
15 F
Impaired pain perception, skeletal deformities, small stature, failure to thrive, recurrent pneumonia, orthostatic hypotension
Progressive degeneration of tongue fungiform papillae and taste buds, impaired taste, excessive drooling, impaired swallowing
2000
Theodorou et al. [62]
IV
N/A
Greece/
N/A
CR
1
4 y
M
Insensitivity to pain, self-mutilation, bone fractures, anhidrosis, mental retardation
Orofacial self-mutilation
2000
Erdem et al. [49]
IV
N/A
Turkey/
N/A
CR
1
10 y
M
Acute tibia osteomyelitis, broken finger tips
Malformed oral configuration, orofacial self-mutilation
1999
Kim et al. [50]
IV
N/A
Korea/
N/A
CR
1
16 m
M
Self-mutilation, fever, anhidrosis, generalized tonic-clonic seizures
Orofacial self-mutilation
1998
Amano et al. [7]
IV
N/A
Japan/
Asian
CS
18
1–22 y
12 M
6 F
Self-mutilation behavior, insensitivity to pain, anhidrosis, infections, malnutrition
Orofacial mutilation, premature loss of teeth, intraoral scars and ulcers, severe bruxism, dental traumata, halitosis
1998
Rodd et al. [51]
II
N/A
UK/
Asian
CR
1
4 y
M
Sensory loss affecting all modalities of sensation predominantly involving the limbs, mutilation, anhidrosis, acropathy of finger tips and feet
Full-thickness loss of the tongue tip, tissue loss from the lower lip, loss of pain sensation
1998
Mass et al. [63]
III
N/A
Israel/ Ashkenazi-Jewish descent
CS
32
5.8–19.8 y
17 M
15 F
Decreased pain sensation, impaired temperature and blood pressure regulation, alacrima, absent tendon reflexes
Orofacial self-mutilation, dental traumata, low caries index, hypersalivation, absence of the fungiform papillae on the tongue
1996
Mass et al. [64]
III
N/A
Israel/ Ashkenazi-Jewish descent
CS
20
5–39 y
14 M
6 F
Decreased pain sensation, impaired temperature and blood pressure regulation, alacrima, absent tendon reflexes
Orofacial self-mutilation
1994
Mass and Gadoth [65]
III
N/A
Israel/ Ashkenazi-Jewish descent
CS
38
N/A
23 M
15 F
Decreased pain sensation, impaired temperature and blood pressure regulation, alacrima, absent tendon reflexes
Dental traumata
1992
Mass et al. [66]
III
N/A
Israel/ Ashkenazi-Jewish descent
CS
66
N/A
N/A
Decreased pain sensation, impaired temperature, impaired blood pressure regulation, absent tendon reflexes, alacrima
Orofacial self-mutilation, dental traumata, low caries index, hypersalivation, absence of the fungiform papillae on the tongue
1989
Kouvelas and Terzoglou [28]
IV
N/A
Greece/
N/A
CR
1
5.5 y
M
Insensitivity to pain, self-mutilation, fever, anhidrosis
Orofacial mutilation
1987
Brahim et al. [67]
IV
N/A
USA/
N/A
CR
2
11 y,
7 y
M
Self-mutilation, fever, anhidrosis, osteomyelitis
Orofacial mutilation
1986
Thompson et al. [68]
III
N/A
USA/
Caucasian
CR
1
31 y
M
Insensitivity to pain, blotching of skin, diminished lacrimation
Orofacial mutilation (including auto-extraction of teeth), diminished taste sensation
2016
Zhang et al. [30]
VIII
PRDM12
N/A
CS
5
23–57 y
4 M
1 F
Insensitivity to pain, normal neurological examinations and intellect, corneal abrasions, lack of tear production, recurrent infections, unexplained self-mutilation
Unexplained orofacial mutilation
Review articles
2015
Haga et al. [5]
IV, V
NTRK1, NGFB
Japan/
N/A
RA
N/A
N/A
N/A
Repeated fractures, joint dislocations, arthritis, osteomyelitis, avascular necrosis, Charcot arthropathy
Oral self-mutilation (including auto-extraction of teeth)
2014
Kumar et al. [69]
IV
NTRK1
India/
N/A
RA
N/A
N/A
N/A
N/A
Orofacial self-mutilation, premature loss of teeth, osteomyelitis, fractures of the jaws
2013
Limeres et al. [26]
IV
N/A
Spain/
N/A
RA
N/A
N/A
N/A
N/A
Oral self-mutilation (including auto-extraction of teeth)
2012
Mass [70]
III
IKBKAP
N/A /
N/A
RA
N/A
N/A
N/A
Insensitivity to pain and temperature, vasomotor instability, respiratory distress, orthostatic hypotension, insensitivity to hypoxia, decreased deep tendon reflexes, alacrima
Absence of fungiform papilla, dental traumata, orofacial self-mutilation, proportionally small jaws, crowding of teeth, low caries rate, hypersalivation, impaired taste sensation
2003
Nagasako et al. [71]
HSAN IV
N/A
USA/
N/A
RA
N/A
N/A
N/A
Insensitivity to pain, self-mutilation, painless fractures, fever, hypohidrosis
Orofacial self-mutilation
CR case report, CS case series, F female, G gender, GA genetics article, HA histological article, IKBKAP inhibitor of kappa light polypeptide gene enhancer in B-cells kinase complex-associated protein, Inter international, m month(s), M male, N number of patients, N/A not available, NGFB nerve growth factor (beta polypeptide), NTRK1 neurotrophic tyrosine kinase-1 receptor, PRDM12 PR domain-containing protein 12, Pub. publication, RA review article, Ts type of study, y year(s), UK United Kingdom, USA United States of America

Case presentation

An 8-month-old white boy of Turkish origin initially presented to the Department of Pedodontics, at Charité – Universitätsmedizin Berlin Hospital, due to an unexplained early loss of his primary lower central incisors. He was the first child of healthy consanguineous parents (second-degree relatives); their younger daughter was healthy. Our patient had multiple injuries on his face and body and in his oral cavity due to self-mutilation (Fig. 1). Further medical history revealed that he was born with a bilateral foot deformity (Fig. 2), which resulted in the mandatory use of an orthopedic appliance, enabling him to walk normally (Fig. 3). At the age of 6 years and 2 months, he had a fracture in the metatarsal bone, leading to bone necrosis. This resulted in the placement of bone plates and the use of a wheelchair for long walking distances. He had several accidents, such as severe burns from boiling water without feeling any pain.
Prior to the first visit to the Department of Pedodontics at the age of 8 months, he had lost both mandibular primary central incisors for unknown reasons only 3 months after they erupted. His mandibular left lateral incisor was loose (mobility, grade 2). In addition, his mandibular left primary second molar (75) showed signs of enamel hypoplasia. He experienced no pain or discomfort during the dental procedures. A year later, he presented at our department due to the further loss of ten of his primary teeth (Fig. 4). The early loss of so many teeth raised suspicion of a systemic disorder. He was referred to the Department of Human Genetics at Charité – Universitätsmedizin Berlin. The following differential diagnoses of auto-aggression syndromes were suspected: congenital insensitivity to pain and anhidrosis (CIPA), Smith–Magenis syndrome, Lesch–Nyhan syndrome, or pantothenate kinase-associated neurodegeneration (PKAN). In addition, the following systemic diseases, which might cause premature loss of teeth, were suspected: Langerhans cell histiocytosis, hypophosphatasia, and Papillon–Lefèvre syndrome. The diagnosis of CIPA syndrome was thought to be closest to his condition. All other suspected auto-aggression syndromes and systemic diseases were excluded based on blood tests, genetic diagnosis, and further clinical examination. However, after deeper investigations, the diagnosis HSAN-VIII was considered the definitive diagnosis of our patient.
Partial dentures for maxilla and mandible were constructed to prevent speech impairment and to enhance his lower facial height (Fig. 5). Due to his high caries activity, an intensive prophylaxis program with continuous follow-up was implemented to avoid further dental deterioration and improve his oral health status. Over the years, with the help of an interdisciplinary medical team and his parents, he has shown great cooperation and completely ceased any sort of self-mutilation behavior.

Discussion

The pediatric dentist was the first to refer our patient to the human genetics department with the suspicion of HSAN syndrome, based on the premature loss of primary teeth and self-mutilation behavior. The initial diagnosis of our patient of CIPA or HSAN-IV was not confirmed by molecular analysis, since it did not detect a mutation in the neurotrophic tyrosine kinase-1 receptor gene (NTRK1), which is the receptor for nerve growth factor (NGF) related to CIPA syndrome [12]. Our patient harbored a homozygous mutation in the recently discovered gene PRDM12 [6]. Therefore, HSAN-VIII was his final diagnosis. Deoxyribonucleic acid (DNA) sequencing of the parents confirmed the segregation of the mutation in the family. The mode of inheritance was autosomal recessive [6]. Self-mutilation behavior is one of the most outstanding characteristics of HSAN syndrome. However, it is also common in other auto-aggression diseases, which makes the diagnosis challenging. Smith–Magenis syndrome was a differential diagnosis concerning the self-inflicted injuries [14], but a causative 17p.11.2 microdeletion was excluded by fluorescence in situ hybridization. As for Lesch–Nyhan syndrome, patients have dystonia and ballism [15], which were not symptoms of our patient. Further analysis did not reveal defects in the hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme, confirming the false diagnosis. PKAN is also characterized by dystonia and therefore was ruled out [1619]. Blood tests excluded the systemic diseases of Langerhans cell histiocytosis and hypophosphatasia [20]. Hypophosphatasia was also excluded because of our patient’s normal total serum alkaline phosphatase activity [2123]. Papillon–Lefèvre syndrome was not confirmed due to the absence of the diffuse palmoplantar hyperkeratosis and the progressive periodontitis [24]. Oral manifestations of HSAN are important, since they are one of the first complaints presented by affected patients. They can be detected early in life, starting with the eruption of the primary dentition [25]. Because of the variability and rarity of the clinical presentation of HSAN, no standard dental management protocols have been established. Patients with HSAN should be treated individually [26]. The dental treatment planning can be affected by several factors, such as age, mental development, and patient’s and parents’ compliance [27]. In the 1960s, the treatment approach for patients with HSAN was extraction of all primary teeth and construction of dentures in order to prevent self-mutilation. Nowadays, there are many dental treatment options for the prevention of self-mutilating behavior, varying from the elimination of sharp tooth surfaces by grinding or restoring them with resin composite, to the use of intraoral appliances such as mouthguards. Since the self-mutilation behavior of patients with HSAN-VIII starts in infancy, it may prove difficult to use intraoral appliances at that point. However, tooth extractions should be considered the last line of treatment. Early loss of teeth is one of the most frequent dental complications of HSAN. It is important to be able to deal with its consequences, such as speech impairment and increased incidence of malocclusions [25, 26, 28]. Professional dental cleaning, behavioral management, and routine check-up appointments were the cornerstones of our treatment plan. Prevention of dental disease is required in patients with HSAN, since caries progression and pulpal involvement can occur without causing any pain or discomfort. The parents of patients with HSAN play a crucial role in the management of the condition, since their psychological support is necessary to help the child understand his or her condition and prevent further injuries [27, 28]. The most critical phase of managing patients with HSAN would be building an understanding of the emotional experience of pain. A psychological approach should be introduced as early as possible [27]. Cognitive behavioral models for self-management and distress regulation have been proposed [29].
The literature search revealed that HSAN-IV (CIPA) is the most discussed form of HSAN in dentistry. Self-mutilation and auto-aggression are the first and most common clinical characteristics in all mentioned HSAN types (Table 2). The literature review results mainly consisted of case reports and case series, which is understandable due to the rarity of the syndrome. In contrast to our case report, a long follow-up period was not reported in the majority of publications. Our case report is, to the best of our knowledge, the first to discuss the oral manifestations and management of HSAN-VIII. Zhang et al. [30] also reported on the clinical characteristics of five patients with HSAN-VIII and was in line with Chen et al. [6]. The clinical characteristics described by Zhang et al. [30] that were found in all patients were: insensitivity to pain, normal neurological examinations and intellect, corneal abrasions, lack of tear production, recurrent infections, and unexplained oral self-mutilation (especially tongue injuries). There is a need for further dental and medical management solutions for these patients, as well as for well-educated practitioners [29]. There are many obstacles that have to be overcome since often there is a lack of resources for research and international collaboration and for accessible database and diagnostic and treatment tools. By expanding our knowledge on genetic and epigenetic factors that are critical for pain sensation, new fields are opened for therapeutic intervention in chronic and neuropathic pain conditions [6, 31, 32].

Conclusions

HSAN-VIII is a rare, complex, recently identified condition mainly characterized by insensitivity to pain and thermal stimuli. The affected persons are vulnerable to various complications and in severe cases, self-mutilation can lead to death. Early identification of the disease is important to prevent all these consequences. The literature contains mainly case reports and case series of patients with HSAN, therefore, there are many knowledge gaps concerning preventive and therapeutic approaches. Treatment efficacy depends on educating the family and supporting the child psychologically. Moreover, an interdisciplinary treatment approach, in which there is medical and dental interdisciplinary cooperation, is required for such patients. A homozygous mutation of the PRDM12 gene, which is responsible for the HSAN-VIII condition, was identified in our patient. Mutations in this gene cause developmental defects in sensory neurons before their transition to nociceptors.

Acknowledgements

Not applicable.

Funding

This study was funded by the authors and their institutions.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
No ethical approval was needed. Informed consent was obtained from the patient’s legal guardians involved in this study.
Written informed consent was obtained from the patient’s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Dearborn G. A case of congenital pure analgesia. J Nerv Ment Dis. 1932;75:612–5.CrossRef Dearborn G. A case of congenital pure analgesia. J Nerv Ment Dis. 1932;75:612–5.CrossRef
2.
Zurück zum Zitat Dyck PJ, Mellinger JF, Reagan TJ, Horowitz SJ, McDonald JW, Litchy WJ, et al. Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy. Brain. 1983;106(Pt 2):373–90.CrossRefPubMed Dyck PJ, Mellinger JF, Reagan TJ, Horowitz SJ, McDonald JW, Litchy WJ, et al. Not 'indifference to pain' but varieties of hereditary sensory and autonomic neuropathy. Brain. 1983;106(Pt 2):373–90.CrossRefPubMed
3.
Zurück zum Zitat Rotthier A, Auer-Grumbach M, Janssens K, Baets J, Penno A, Almeida-Souza L, et al. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet. 2010;87:513–22.CrossRefPubMedPubMedCentral Rotthier A, Auer-Grumbach M, Janssens K, Baets J, Penno A, Almeida-Souza L, et al. Mutations in the SPTLC2 subunit of serine palmitoyltransferase cause hereditary sensory and autonomic neuropathy type I. Am J Hum Genet. 2010;87:513–22.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Yuan J, Matsuura E, Higuchi Y, Hashiguchi A, Nakamura T, Nozuma S, et al. Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation. Neurology. 2013;80:1641–9.CrossRefPubMed Yuan J, Matsuura E, Higuchi Y, Hashiguchi A, Nakamura T, Nozuma S, et al. Hereditary sensory and autonomic neuropathy type IID caused by an SCN9A mutation. Neurology. 2013;80:1641–9.CrossRefPubMed
5.
Zurück zum Zitat Haga N, Kubota M, Miwa Z. Japanese Research Group on Congenital Insensitivity to Pain. Hereditary sensory and autonomic neuropathy types IV and V in Japan. Pediatr Int. 2015;57:30–6.CrossRefPubMed Haga N, Kubota M, Miwa Z. Japanese Research Group on Congenital Insensitivity to Pain. Hereditary sensory and autonomic neuropathy types IV and V in Japan. Pediatr Int. 2015;57:30–6.CrossRefPubMed
6.
Zurück zum Zitat Chen YC, Auer-Grumbach M, Matsukawa S, Zitzelsberger M, Themistocleous AC, Strom TM, et al. Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet. 2015;47:803–8.CrossRefPubMed Chen YC, Auer-Grumbach M, Matsukawa S, Zitzelsberger M, Themistocleous AC, Strom TM, et al. Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet. 2015;47:803–8.CrossRefPubMed
7.
Zurück zum Zitat Amano A, Akiyama S, Ikeda M, Morisaki I. Oral manifestations of hereditary sensory and autonomic neuropathy type IV. Congenital insensitivity to pain with anhidrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:425–31.CrossRefPubMed Amano A, Akiyama S, Ikeda M, Morisaki I. Oral manifestations of hereditary sensory and autonomic neuropathy type IV. Congenital insensitivity to pain with anhidrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:425–31.CrossRefPubMed
8.
Zurück zum Zitat Gao L, Guo H, Ye N, Bai Y, Liu X, Yu P, et al. Oral and craniofacial manifestations and two novel missense mutations of the NTRK1 gene identified in the patient with congenital insensitivity to pain with anhidrosis. PLoS One. 2013;8:e66863.CrossRefPubMedPubMedCentral Gao L, Guo H, Ye N, Bai Y, Liu X, Yu P, et al. Oral and craniofacial manifestations and two novel missense mutations of the NTRK1 gene identified in the patient with congenital insensitivity to pain with anhidrosis. PLoS One. 2013;8:e66863.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Neves BG, Roza RT, Castro GF. Traumatic lesions from congenital insensitivity to pain with anhidrosis in a pediatric patient: dental management. Dent Traumatol. 2009;25:545–9.CrossRefPubMed Neves BG, Roza RT, Castro GF. Traumatic lesions from congenital insensitivity to pain with anhidrosis in a pediatric patient: dental management. Dent Traumatol. 2009;25:545–9.CrossRefPubMed
10.
Zurück zum Zitat Bodner L, Woldenberg Y, Pinsk V, Levy J. Orofacial manifestations of congenital insensitivity to pain with anhidrosis: a report of 24 cases. ASDC J Dent Child. 2002;69:293–6. 235. Bodner L, Woldenberg Y, Pinsk V, Levy J. Orofacial manifestations of congenital insensitivity to pain with anhidrosis: a report of 24 cases. ASDC J Dent Child. 2002;69:293–6. 235.
11.
Zurück zum Zitat Ashwin DP, Chandan GD, Jasleen HK, Rajkumar GC, Rudresh KB, Prashanth R. Hereditary sensory and autosomal peripheral neuropathy-type IV: case series and review of literature. Oral Maxillofac Surg. 2015;19:117–23.CrossRefPubMed Ashwin DP, Chandan GD, Jasleen HK, Rajkumar GC, Rudresh KB, Prashanth R. Hereditary sensory and autosomal peripheral neuropathy-type IV: case series and review of literature. Oral Maxillofac Surg. 2015;19:117–23.CrossRefPubMed
12.
Zurück zum Zitat Bonkowsky JL, Johnson J, Carey JC, Smith AG, Swoboda KJ. An infant with primary tooth loss and palmar hyperkeratosis: a novel mutation in the NTRK1 gene causing congenital insensitivity to pain with anhidrosis. Pediatrics. 2003;112:e237–41.CrossRefPubMed Bonkowsky JL, Johnson J, Carey JC, Smith AG, Swoboda KJ. An infant with primary tooth loss and palmar hyperkeratosis: a novel mutation in the NTRK1 gene causing congenital insensitivity to pain with anhidrosis. Pediatrics. 2003;112:e237–41.CrossRefPubMed
13.
Zurück zum Zitat Ravichandra KS, Kandregula CR, Koya S, Lakhotia D. Congenital insensitivity to pain and anhydrosis: diagnostic and therapeutic dilemmas revisited. Int J Clin Pediatr Dent. 2015;8:75–81.CrossRefPubMedPubMedCentral Ravichandra KS, Kandregula CR, Koya S, Lakhotia D. Congenital insensitivity to pain and anhydrosis: diagnostic and therapeutic dilemmas revisited. Int J Clin Pediatr Dent. 2015;8:75–81.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Girirajan S, Elsas LJ, Devriendt K, Elsea 2nd SH. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet. 2005;42:820–8. Girirajan S, Elsas LJ, Devriendt K, Elsea 2nd SH. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet. 2005;42:820–8.
15.
Zurück zum Zitat Pozzi M, Piccinini L, Gallo M, Motta F, Radice S, Clementi E. Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen. Orphanet J Rare Dis. 2014;9:208.CrossRefPubMedPubMedCentral Pozzi M, Piccinini L, Gallo M, Motta F, Radice S, Clementi E. Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen. Orphanet J Rare Dis. 2014;9:208.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Brunetti D, Dusi S, Morbin M, Uggetti A, Moda F, D'Amato I, et al. Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model. Hum Mol Genet. 2012;21:5294–305.CrossRefPubMedPubMedCentral Brunetti D, Dusi S, Morbin M, Uggetti A, Moda F, D'Amato I, et al. Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model. Hum Mol Genet. 2012;21:5294–305.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Gregory A, Hayflick SJ, et al. Pantothenate Kinase-Associated Neurodegeneration. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, editors. GeneReviews(R). Seattle: University of Washington, Seattle University of Washington, Seattle; 1993. All rights reserved. Gregory A, Hayflick SJ, et al. Pantothenate Kinase-Associated Neurodegeneration. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, editors. GeneReviews(R). Seattle: University of Washington, Seattle University of Washington, Seattle; 1993. All rights reserved.
18.
Zurück zum Zitat Gregory A, Hayflick SJ. PANK2 mutation screening recommended to confirm diagnosis of pantothenate kinase-associated neurodegeneration. AJNR Am J Neuroradiol. 2006;27:951.PubMed Gregory A, Hayflick SJ. PANK2 mutation screening recommended to confirm diagnosis of pantothenate kinase-associated neurodegeneration. AJNR Am J Neuroradiol. 2006;27:951.PubMed
19.
Zurück zum Zitat Yapici Z, Akcakaya NH, Tekturk P, Iseri SA, Ozbek U. A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia. Brain Dev. 2016;38(8):755–8.CrossRefPubMed Yapici Z, Akcakaya NH, Tekturk P, Iseri SA, Ozbek U. A novel gene mutation in PANK2 in a patient with severe jaw-opening dystonia. Brain Dev. 2016;38(8):755–8.CrossRefPubMed
20.
Zurück zum Zitat Calming U, Henter JI. Elevated erythrocyte sedimentation rate and thrombocytosis as possible indicators of active disease in Langerhans' cell histiocytosis. Acta Paediatr. 1998;87:1085–7.CrossRefPubMed Calming U, Henter JI. Elevated erythrocyte sedimentation rate and thrombocytosis as possible indicators of active disease in Langerhans' cell histiocytosis. Acta Paediatr. 1998;87:1085–7.CrossRefPubMed
22.
Zurück zum Zitat Jaruratanasirikul S, Chanvitan P. Hypophosphatasia: the importance of alkaline phosphatase in bone mineralization. J Med Assoc Thai. 1999;82:1268–72.PubMed Jaruratanasirikul S, Chanvitan P. Hypophosphatasia: the importance of alkaline phosphatase in bone mineralization. J Med Assoc Thai. 1999;82:1268–72.PubMed
23.
Zurück zum Zitat Reibel A, Maniere MC, Clauss F, Droz D, Alembik Y, Mornet E, et al. Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis. 2009;4:6.CrossRefPubMedPubMedCentral Reibel A, Maniere MC, Clauss F, Droz D, Alembik Y, Mornet E, et al. Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis. 2009;4:6.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Dhanrajani PJ. Papillon-Lefevre syndrome: clinical presentation and a brief review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:e1–7.CrossRefPubMed Dhanrajani PJ. Papillon-Lefevre syndrome: clinical presentation and a brief review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:e1–7.CrossRefPubMed
25.
Zurück zum Zitat Butler J, Fleming P, Webb D. Congenital insensitivity to pain – review and report of a case with dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:58–62.CrossRefPubMed Butler J, Fleming P, Webb D. Congenital insensitivity to pain – review and report of a case with dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:58–62.CrossRefPubMed
26.
Zurück zum Zitat Limeres J, Feijoo JF, Baluja F, Seoane JM, Diniz M, Diz P. Oral self-injury: an update. Dent Traumatol. 2013;29:8–14.CrossRefPubMed Limeres J, Feijoo JF, Baluja F, Seoane JM, Diniz M, Diz P. Oral self-injury: an update. Dent Traumatol. 2013;29:8–14.CrossRefPubMed
27.
Zurück zum Zitat Schalka MM, Correa MS, Ciamponi AL. Congenital insensitivity-to-pain with anhidrosis (CIPA): a case report with 4-year follow-up. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:769–73.CrossRefPubMed Schalka MM, Correa MS, Ciamponi AL. Congenital insensitivity-to-pain with anhidrosis (CIPA): a case report with 4-year follow-up. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:769–73.CrossRefPubMed
28.
Zurück zum Zitat Kouvelas N, Terzoglou C. Congenital insensitivity to pain with anhidrosis: case report. Pediatr Dent. 1989;11:47–51.PubMed Kouvelas N, Terzoglou C. Congenital insensitivity to pain with anhidrosis: case report. Pediatr Dent. 1989;11:47–51.PubMed
29.
Zurück zum Zitat Graham CD, Gouick J, Krahe C, Gillanders D. A systematic review of the use of Acceptance and Commitment Therapy (ACT) in chronic disease and long-term conditions. Clin Psychol Rev. 2016;46:46–58.CrossRefPubMed Graham CD, Gouick J, Krahe C, Gillanders D. A systematic review of the use of Acceptance and Commitment Therapy (ACT) in chronic disease and long-term conditions. Clin Psychol Rev. 2016;46:46–58.CrossRefPubMed
30.
Zurück zum Zitat Zhang S, Sharif SM, Chen YC, Valente EM, Ahmed M, Sheridan E, Bennett C, Woods G. Clinical features for diagnosis and management of patients with PRMD12 congenital insensitivity to pain. J Med Genet. 2016;53:533–5.CrossRefPubMedPubMedCentral Zhang S, Sharif SM, Chen YC, Valente EM, Ahmed M, Sheridan E, Bennett C, Woods G. Clinical features for diagnosis and management of patients with PRMD12 congenital insensitivity to pain. J Med Genet. 2016;53:533–5.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Haga N, Kubota M, Miwa Z. Epidemiology of hereditary sensory and autonomic neuropathy type IV and V in Japan. Am J Med Genet A. 2013;161A:871–4.CrossRefPubMed Haga N, Kubota M, Miwa Z. Epidemiology of hereditary sensory and autonomic neuropathy type IV and V in Japan. Am J Med Genet A. 2013;161A:871–4.CrossRefPubMed
34.
Zurück zum Zitat Rotthier A, Baets J, Timmerman V, Janssens K. Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol. 2012;8:73–85.CrossRefPubMed Rotthier A, Baets J, Timmerman V, Janssens K. Mechanisms of disease in hereditary sensory and autonomic neuropathies. Nat Rev Neurol. 2012;8:73–85.CrossRefPubMed
35.
Zurück zum Zitat Kok C, Kennerson ML, Spring PJ, Ing AJ, Pollard JD, Nicholson GA. A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24. Am J Hum Genet. 2003;73:632–7.CrossRefPubMedPubMedCentral Kok C, Kennerson ML, Spring PJ, Ing AJ, Pollard JD, Nicholson GA. A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24. Am J Hum Genet. 2003;73:632–7.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Penno A, Reilly MM, Houlden H, Laura M, Rentsch K, Niederkofler V, et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem. 2010;285:11178–87.CrossRefPubMedPubMedCentral Penno A, Reilly MM, Houlden H, Laura M, Rentsch K, Niederkofler V, et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem. 2010;285:11178–87.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Guelly C, Zhu PP, Leonardis L, Papic L, Zidar J, Schabhuttl M, et al. Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet. 2011;88:99–105.CrossRefPubMedPubMedCentral Guelly C, Zhu PP, Leonardis L, Papic L, Zidar J, Schabhuttl M, et al. Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet. 2011;88:99–105.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet. 2011;43:595–600.CrossRefPubMedPubMedCentral Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet. 2011;43:595–600.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Kornak U, Mademan I, Schinke M, Voigt M, Krawitz P, Hecht J, et al. Sensory neuropathy with bone destruction due to a mutation in the membrane-shaping atlastin GTPase 3. Brain. 2014;137:683–92.CrossRefPubMed Kornak U, Mademan I, Schinke M, Voigt M, Krawitz P, Hecht J, et al. Sensory neuropathy with bone destruction due to a mutation in the membrane-shaping atlastin GTPase 3. Brain. 2014;137:683–92.CrossRefPubMed
40.
Zurück zum Zitat Lafreniere RG, MacDonald ML, Dube MP, MacFarlane J, O'Driscoll M, Brais B, et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet. 2004;74:1064–73.CrossRefPubMedPubMedCentral Lafreniere RG, MacDonald ML, Dube MP, MacFarlane J, O'Driscoll M, Brais B, et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet. 2004;74:1064–73.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Ilgaz Aydinlar E, Rolfs A, Serteser M, Parman Y. Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family. Muscle Nerve. 2014;49:774–5.CrossRefPubMed Ilgaz Aydinlar E, Rolfs A, Serteser M, Parman Y. Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family. Muscle Nerve. 2014;49:774–5.CrossRefPubMed
42.
Zurück zum Zitat Riviere JB, Ramalingam S, Lavastre V, Shekarabi M, Holbert S, Lafontaine J, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet. 2011;89:219–30.CrossRefPubMedPubMedCentral Riviere JB, Ramalingam S, Lavastre V, Shekarabi M, Holbert S, Lafontaine J, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet. 2011;89:219–30.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444:894–8.CrossRefPubMed Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, Springell K, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444:894–8.CrossRefPubMed
44.
Zurück zum Zitat Guven Y, Altunoglu U, Aktoren O, Uyguner ZO, Kayserili H, Kaewkahya M, et al. Twins with hereditary sensory and autonomic neuropathy type IV with preserved periodontal sensation. Eur J Med Genet. 2014;57:240–6.CrossRefPubMed Guven Y, Altunoglu U, Aktoren O, Uyguner ZO, Kayserili H, Kaewkahya M, et al. Twins with hereditary sensory and autonomic neuropathy type IV with preserved periodontal sensation. Eur J Med Genet. 2014;57:240–6.CrossRefPubMed
45.
Zurück zum Zitat Hutton A, McKaig S. The dental management of a child with congenital insensitivity to pain. Dent Update. 2010;37:180–2. 185. Hutton A, McKaig S. The dental management of a child with congenital insensitivity to pain. Dent Update. 2010;37:180–2. 185.
46.
Zurück zum Zitat Zilberman U, Zilberman S, Keinan D, Elyiahu M. Enamel development in primary molars from children with familial dysautonomia. Arch Oral Biol. 2010;55:907–12.CrossRefPubMed Zilberman U, Zilberman S, Keinan D, Elyiahu M. Enamel development in primary molars from children with familial dysautonomia. Arch Oral Biol. 2010;55:907–12.CrossRefPubMed
47.
Zurück zum Zitat Singla S, Marwah N, Dutta S. Congenital insensitivity to pain (hereditary sensory and autonomic neuropathy type V): a rare case report. J Dent Child (Chic). 2008;75:207–11. Singla S, Marwah N, Dutta S. Congenital insensitivity to pain (hereditary sensory and autonomic neuropathy type V): a rare case report. J Dent Child (Chic). 2008;75:207–11.
48.
Zurück zum Zitat Siqueira SR, Okada M, Lino AM, Teixeira MJ, Siqueira JT. Proposal for a standardized protocol for the systematic orofacial examination of patients with Hereditary Sensory Radicular Neuropathy. Int Endod J. 2006;39:905–15.CrossRefPubMed Siqueira SR, Okada M, Lino AM, Teixeira MJ, Siqueira JT. Proposal for a standardized protocol for the systematic orofacial examination of patients with Hereditary Sensory Radicular Neuropathy. Int Endod J. 2006;39:905–15.CrossRefPubMed
49.
Zurück zum Zitat Erdem TL, Ozcan I, Ilguy D, Sirin S. Hereditary sensory and autonomic neuropathy: review and a case report with dental implications. J Oral Rehabil. 2000;27:180–3.CrossRefPubMed Erdem TL, Ozcan I, Ilguy D, Sirin S. Hereditary sensory and autonomic neuropathy: review and a case report with dental implications. J Oral Rehabil. 2000;27:180–3.CrossRefPubMed
50.
Zurück zum Zitat Kim JS, Woo YJ, Kim GM, Kim CJ, Ma JS, Hwang TJ, et al. Congenital insensitivity to pain with anhidrosis: a case report. J Korean Med Sci. 1999;14:460–4.CrossRefPubMedPubMedCentral Kim JS, Woo YJ, Kim GM, Kim CJ, Ma JS, Hwang TJ, et al. Congenital insensitivity to pain with anhidrosis: a case report. J Korean Med Sci. 1999;14:460–4.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Rodd HD, Loescher AR, Boissonade FM. Immunocytochemical and electron-microscopic features of tooth pulp innervation in hereditary sensory and autonomic neuropathy. Arch Oral Biol. 1998;43:445–54.CrossRefPubMed Rodd HD, Loescher AR, Boissonade FM. Immunocytochemical and electron-microscopic features of tooth pulp innervation in hereditary sensory and autonomic neuropathy. Arch Oral Biol. 1998;43:445–54.CrossRefPubMed
52.
Zurück zum Zitat Mass E, Gadoth N, Harell D, Wolff A. Can salivary composition and high flow rate explain the low caries rate in children with familial dysautonomia? Pediatr Dent. 2002;24:581–6.PubMed Mass E, Gadoth N, Harell D, Wolff A. Can salivary composition and high flow rate explain the low caries rate in children with familial dysautonomia? Pediatr Dent. 2002;24:581–6.PubMed
53.
Zurück zum Zitat Edvardson S, Cinnamon Y, Jalas C, Shaag A, Maayan C, Axelrod FB, et al. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol. 2012;71:569–72.CrossRefPubMed Edvardson S, Cinnamon Y, Jalas C, Shaag A, Maayan C, Axelrod FB, et al. Hereditary sensory autonomic neuropathy caused by a mutation in dystonin. Ann Neurol. 2012;71:569–72.CrossRefPubMed
54.
Zurück zum Zitat Leipold E, Liebmann L, Korenke GC, Heinrich T, Giesselmann S, Baets J, et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet. 2013;45:1399–404.CrossRefPubMed Leipold E, Liebmann L, Korenke GC, Heinrich T, Giesselmann S, Baets J, et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet. 2013;45:1399–404.CrossRefPubMed
55.
Zurück zum Zitat Woods CG, Babiker MO, Horrocks I, Tolmie J, Kurth I. The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p.L811P. Eur J Hum Genet. 2015;23:1434.CrossRefPubMedPubMedCentral Woods CG, Babiker MO, Horrocks I, Tolmie J, Kurth I. The phenotype of congenital insensitivity to pain due to the NaV1.9 variant p.L811P. Eur J Hum Genet. 2015;23:1434.CrossRefPubMedPubMedCentral
56.
Zurück zum Zitat Eregowda NI, Yadav S, Parameshwarappa P, Basavraj RK. A Girl with No Pain: Congenital Insensitivity To Pain and Anhidrosis (HSAN) Type IV – A Case Report. J Clin Diagn Res. 2016;10:Zl01–02. Eregowda NI, Yadav S, Parameshwarappa P, Basavraj RK. A Girl with No Pain: Congenital Insensitivity To Pain and Anhidrosis (HSAN) Type IV – A Case Report. J Clin Diagn Res. 2016;10:Zl01–02.
57.
Zurück zum Zitat Ozkaya AK, Guler E, Arik E, Namli AR, Cevizli D, Gungor O. A case of congenital insensitivity to pain with anhidrosis. Turk Pediatri Ars. 2014;49:177–9.CrossRefPubMedPubMedCentral Ozkaya AK, Guler E, Arik E, Namli AR, Cevizli D, Gungor O. A case of congenital insensitivity to pain with anhidrosis. Turk Pediatri Ars. 2014;49:177–9.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Fruchtman Y, Perry ZH, Levy J. Morbidity characteristics of patients with congenital insensitivity to pain with anhidrosis (CIPA). J Pediatr Endocrinol Metab. 2013;26:325–32.CrossRefPubMed Fruchtman Y, Perry ZH, Levy J. Morbidity characteristics of patients with congenital insensitivity to pain with anhidrosis (CIPA). J Pediatr Endocrinol Metab. 2013;26:325–32.CrossRefPubMed
59.
Zurück zum Zitat Paduano S, Iodice G, Farella M, Silva R, Michelotti A. Orthodontic treatment and management of limited mouth opening and oral lesions in a patient with congenital insensitivity to pain: case report. J Oral Rehabil. 2009;36:71–8.CrossRefPubMed Paduano S, Iodice G, Farella M, Silva R, Michelotti A. Orthodontic treatment and management of limited mouth opening and oral lesions in a patient with congenital insensitivity to pain: case report. J Oral Rehabil. 2009;36:71–8.CrossRefPubMed
60.
Zurück zum Zitat Romero M, Simon R, Garcia-Recuero JI, Romance A. Dental management of oral self-mutilation in neurological patients: a case of congenital insensitivity to pain with anhidrosis. Med Oral Patol Oral Cir Bucal. 2008;13:E644–647.PubMed Romero M, Simon R, Garcia-Recuero JI, Romance A. Dental management of oral self-mutilation in neurological patients: a case of congenital insensitivity to pain with anhidrosis. Med Oral Patol Oral Cir Bucal. 2008;13:E644–647.PubMed
61.
Zurück zum Zitat Wolff A, Harell D, Gadoth N, Mass E. Submandibular and sublingual salivary gland function in familial dysautonomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:315–9.CrossRefPubMed Wolff A, Harell D, Gadoth N, Mass E. Submandibular and sublingual salivary gland function in familial dysautonomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:315–9.CrossRefPubMed
62.
Zurück zum Zitat Theodorou SD, Klimentopoulou AE, Papalouka E. Congenital insensitivity to pain with anhidrosis. Report of a case and review of the literature. Acta Orthop Belg. 2000;66:137–45.PubMed Theodorou SD, Klimentopoulou AE, Papalouka E. Congenital insensitivity to pain with anhidrosis. Report of a case and review of the literature. Acta Orthop Belg. 2000;66:137–45.PubMed
63.
Zurück zum Zitat Mass E, Brin I, Belostoky L, Maayan C, Gadoth N. A cephalometric evaluation of craniofacial morphology in familial dysautonomia. Cleft Palate Craniofac J. 1998;35:120–6.CrossRefPubMed Mass E, Brin I, Belostoky L, Maayan C, Gadoth N. A cephalometric evaluation of craniofacial morphology in familial dysautonomia. Cleft Palate Craniofac J. 1998;35:120–6.CrossRefPubMed
64.
Zurück zum Zitat Mass E, Zilberman U, Gadoth N. Abnormal enamel and pulp dimensions in familial dysautonomia. J Dent Res. 1996;75:1747–52.CrossRefPubMed Mass E, Zilberman U, Gadoth N. Abnormal enamel and pulp dimensions in familial dysautonomia. J Dent Res. 1996;75:1747–52.CrossRefPubMed
65.
Zurück zum Zitat Mass E, Gadoth N. Oro-dental self-mutilation in familial dysautonomia. J Oral Pathol Med. 1994;23:273–6.CrossRefPubMed Mass E, Gadoth N. Oro-dental self-mutilation in familial dysautonomia. J Oral Pathol Med. 1994;23:273–6.CrossRefPubMed
66.
Zurück zum Zitat Mass E, Sarnat H, Ram D, Gadoth N. Dental and oral findings in patients with familial dysautonomia. Oral Surg Oral Med Oral Pathol. 1992;74:305–11.CrossRefPubMed Mass E, Sarnat H, Ram D, Gadoth N. Dental and oral findings in patients with familial dysautonomia. Oral Surg Oral Med Oral Pathol. 1992;74:305–11.CrossRefPubMed
67.
Zurück zum Zitat Brahim JS, Roberts MW, McDonald HD. Oral and maxillofacial complications associated with congenital sensory neuropathy with anhydrosis: report of two cases. J Oral Maxillofac Surg. 1987;45:331–4.CrossRefPubMed Brahim JS, Roberts MW, McDonald HD. Oral and maxillofacial complications associated with congenital sensory neuropathy with anhydrosis: report of two cases. J Oral Maxillofac Surg. 1987;45:331–4.CrossRefPubMed
68.
Zurück zum Zitat Thompson BH, Hartwell GR, Ekvall WM, Koudelka BM. Endodontic management of a patient with familial dysautonomia. J Endod. 1986;12:170–3.CrossRefPubMed Thompson BH, Hartwell GR, Ekvall WM, Koudelka BM. Endodontic management of a patient with familial dysautonomia. J Endod. 1986;12:170–3.CrossRefPubMed
69.
Zurück zum Zitat Kumar A, Naik P, Jaishankar HP. Congenital insensitivity to pain: Review with dental implications. Indian J Pain. 2014;28:13.CrossRef Kumar A, Naik P, Jaishankar HP. Congenital insensitivity to pain: Review with dental implications. Indian J Pain. 2014;28:13.CrossRef
70.
Zurück zum Zitat Mass E. A review of the oro-dento-facial characteristics of hereditary sensory and autonomic neuropathy type III (familial dysautonomia). Spec Care Dentist. 2012;32:15–20.CrossRefPubMed Mass E. A review of the oro-dento-facial characteristics of hereditary sensory and autonomic neuropathy type III (familial dysautonomia). Spec Care Dentist. 2012;32:15–20.CrossRefPubMed
71.
Zurück zum Zitat Nagasako EM, Oaklander AL, Dworkin RH. Congenital insensitivity to pain: an update. Pain. 2003;101:213–9.CrossRefPubMed Nagasako EM, Oaklander AL, Dworkin RH. Congenital insensitivity to pain: an update. Pain. 2003;101:213–9.CrossRefPubMed
Metadaten
Titel
Oral manifestations, dental management, and a rare homozygous mutation of the PRDM12 gene in a boy with hereditary sensory and autonomic neuropathy type VIII: a case report and review of the literature
verfasst von
Karim Elhennawy
Seif Reda
Christian Finke
Luitgard Graul-Neumann
Paul-Georg Jost-Brinkmann
Theodosia Bartzela
Publikationsdatum
01.12.2017
Verlag
BioMed Central
Erschienen in
Journal of Medical Case Reports / Ausgabe 1/2017
Elektronische ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1387-z

Weitere Artikel der Ausgabe 1/2017

Journal of Medical Case Reports 1/2017 Zur Ausgabe